TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs7223966
log Bayes Factor = 0.0594609
Chromosome 17   position 61,893,398  (GRCh37) Explore rs7223966 on Ensembl!
Variant rs7223966 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)
0.194 0.806 0.000
M05.9 Seropositive rheumatoid arthritis, unspecified
0.191 0.809 0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)
0.186 0.814 0.000
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.150 0.850 0.000
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)
0.148 0.852 0.000
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)
0.145 0.855 0.000
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)
0.145 0.855 0.000
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)
0.137 0.863 0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)
0.137 0.863 0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)
0.137 0.863 0.000
M05 Seropositive rheumatoid arthritis
0.133 0.867 0.000
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)
0.130 0.870 0.000
M05.8 Other seropositive rheumatoid arthritis
0.118 0.882 0.000
M05.80 Other seropositive rheumatoid arthritis (Multiple sites)
0.106 0.894 0.000
M05.2 Rheumatoid vasculitis
0.103 0.897 0.000
M05.3 Rheumatoid arthritis with involvement of other organs and systems
0.095 0.904 0.000
M05.1 Rheumatoid lung disease
0.095 0.904 0.000
M05.0 Felty's syndrome
0.095 0.904 0.000
M05.89 Other seropositive rheumatoid arthritis (Site unspecified)
0.091 0.909 0.000
M05.88 Other seropositive rheumatoid arthritis (Other)
0.085 0.915 0.000
M05.87 Other seropositive rheumatoid arthritis (Ankle and foot)
0.085 0.915 0.000
M05.86 Other seropositive rheumatoid arthritis (Lower leg)
0.085 0.915 0.000
M05.85 Other seropositive rheumatoid arthritis (Pelvic region and thigh)
0.085 0.915 0.000
M05.84 Other seropositive rheumatoid arthritis (Hand)
0.085 0.915 0.000
M05.83 Other seropositive rheumatoid arthritis (Forearm)
0.085 0.915 0.000
M05.82 Other seropositive rheumatoid arthritis (Upper arm)
0.085 0.915 0.000
M05.81 Other seropositive rheumatoid arthritis (Shoulder region)
0.085 0.915 0.000
M05.20 Rheumatoid vasculitis (Multiple sites)
0.081 0.919 0.000
M05.29 Rheumatoid vasculitis (Site unspecified)
0.074 0.926 0.000
M05.28 Rheumatoid vasculitis (Other)
0.074 0.926 0.000
M05.27 Rheumatoid vasculitis (Ankle and foot)
0.074 0.926 0.000
M05.26 Rheumatoid vasculitis (Lower leg)
0.074 0.926 0.000
M05.25 Rheumatoid vasculitis (Pelvic region and thigh)
0.074 0.926 0.000
M05.24 Rheumatoid vasculitis (Hand)
0.074 0.926 0.000
M05.23 Rheumatoid vasculitis (Forearm)
0.074 0.926 0.000
M05.22 Rheumatoid vasculitis (Upper arm)
0.074 0.926 0.000
M05.21 Rheumatoid vasculitis (Shoulder region)
0.074 0.926 0.000
M05.09 Felty's syndrome (Site unspecified)
0.069 0.931 0.000
M05.08 Felty's syndrome (Other)
0.069 0.931 0.000
M05.07 Felty's syndrome (Ankle and foot)
0.069 0.931 0.000
M05.06 Felty's syndrome (Lower leg)
0.069 0.931 0.000
M05.05 Felty's syndrome (Pelvic region and thigh)
0.069 0.931 0.000
M05.04 Felty's syndrome (Hand)
0.069 0.931 0.000
M05.03 Felty's syndrome (Forearm)
0.069 0.931 0.000
M05.02 Felty's syndrome (Upper arm)
0.069 0.931 0.000
M05.01 Felty's syndrome (Shoulder region)
0.069 0.931 0.000
M05.00 Felty's syndrome (Multiple sites)
0.069 0.931 0.000
M05.19 Rheumatoid lung disease (Site unspecified)
0.069 0.931 0.000
M05.18 Rheumatoid lung disease (Other)
0.069 0.931 0.000
M05.17 Rheumatoid lung disease (Ankle and foot)
0.069 0.931 0.000
M05.16 Rheumatoid lung disease (Lower leg)
0.069 0.931 0.000
M05.15 Rheumatoid lung disease (Pelvic region and thigh)
0.069 0.931 0.000
M05.14 Rheumatoid lung disease (Hand)
0.069 0.931 0.000
M05.13 Rheumatoid lung disease (Forearm)
0.069 0.931 0.000
M05.12 Rheumatoid lung disease (Upper arm)
0.069 0.931 0.000
M05.11 Rheumatoid lung disease (Shoulder region)
0.069 0.931 0.000
M05.10 Rheumatoid lung disease (Multiple sites)
0.069 0.931 0.000
M05.39 Rheumatoid arthritis with involvement of other organs and systems (Site unspecified)
0.069 0.931 0.000
M05.38 Rheumatoid arthritis with involvement of other organs and systems (Other)
0.069 0.931 0.000
M05.37 Rheumatoid arthritis with involvement of other organs and systems (Ankle and foot)
0.069 0.931 0.000
M05.36 Rheumatoid arthritis with involvement of other organs and systems (Lower leg)
0.069 0.931 0.000
M05.35 Rheumatoid arthritis with involvement of other organs and systems (Pelvic region and thigh)
0.069 0.931 0.000
M05.34 Rheumatoid arthritis with involvement of other organs and systems (Hand)
0.069 0.931 0.000
M05.33 Rheumatoid arthritis with involvement of other organs and systems (Forearm)
0.069 0.931 0.000
M05.32 Rheumatoid arthritis with involvement of other organs and systems (Upper arm)
0.069 0.931 0.000
M05.31 Rheumatoid arthritis with involvement of other organs and systems (Shoulder region)
0.069 0.931 0.000
M05.30 Rheumatoid arthritis with involvement of other organs and systems (Multiple sites)
0.069 0.931 0.000
T43.2 Other and unspecified antidepressants
0.035 0.965 0.000
R19.8 Other specified symptoms and signs involving the digestive system and abdomen
0.033 0.967 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.032 0.968 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.032 0.968 0.000
M43.16 Spondylolisthesis (Lumbar region)
0.000 0.972 0.028
T43.3 Phenothiazine antipsychotics and neuroleptics
0.028 0.972 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.027 0.973 0.000
T43.6 Psychostimulants with abuse potential
0.025 0.975 0.000
N71.1 Chronic inflammatory disease of uterus
0.025 0.975 0.000
T43.9 Psychotropic drug, unspecified
0.023 0.977 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.023 0.977 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.023 0.977 0.000
N71.9 Inflammatory disease of uterus, unspecified
0.022 0.978 0.000
N71 Inflammatory disease of uterus, except cervix
0.022 0.978 0.000
M43.1 Spondylolisthesis
0.000 0.979 0.021
M43.17 Spondylolisthesis (Lumbosacral region)
0.000 0.982 0.017
M43.12 Spondylolisthesis (Cervical region)
0.000 0.983 0.017
N71.0 Acute inflammatory disease of uterus
0.016 0.984 0.000
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)
0.000 0.984 0.016
M43.15 Spondylolisthesis (Thoracolumbar region)
0.000 0.984 0.016
M43.14 Spondylolisthesis (Thoracic region)
0.000 0.984 0.016
M43.13 Spondylolisthesis (Cervicothoracic region)
0.000 0.984 0.016
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)
0.000 0.984 0.016
M43.10 Spondylolisthesis (Multiple sites in spine)
0.000 0.984 0.016
E21.3 Hyperparathyroidism, unspecified
0.015 0.985 0.000
E10.1 With ketoacidosis
0.000 0.986 0.014
M43 Other deforming dorsopathies
0.000 0.986 0.014
M43.19 Spondylolisthesis (Site unspecified)
0.000 0.986 0.013
M43.0 Spondylolysis
0.000 0.988 0.012
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.012 0.988 0.000
M43.06 Spondylolysis (Lumbar region)
0.000 0.989 0.011
Z80.4 Family history of malignant neoplasm of genital organs
0.000 0.989 0.011
T36-T50 Poisoning by drugs, medicaments and biological substances
0.011 0.989 0.000
E21.5 Disorder of parathyroid gland, unspecified
0.010 0.990 0.000
M43.9 Deforming dorsopathy, unspecified
0.000 0.990 0.010
M43.8 Other specified deforming dorsopathies
0.000 0.990 0.010
M43.5 Other recurrent vertebral subluxation
0.000 0.990 0.010
M43.4 Other recurrent atlantoaxial subluxation
0.000 0.990 0.010
M43.3 Recurrent atlantoaxial subluxation with myelopathy
0.000 0.990 0.010
M43.2 Other fusion of spine
0.000 0.990 0.010
L89 Decubitus ulcer
0.010 0.990 0.000
M43.6 Torticollis
0.000 0.990 0.010
L89.1 Stage II decubitus ulcer
0.010 0.990 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.010 0.990 0.000
L89.9 Decubitus ulcer and pressure area, unspecified
0.010 0.990 0.000
E21.0 Primary hyperparathyroidism
0.010 0.990 0.000
M43.09 Spondylolysis (Site unspecified)
0.000 0.990 0.009
U80.1 Methicillin resistant agent
0.000 0.990 0.010
E21.2 Other hyperparathyroidism
0.009 0.991 0.000
L89.0 Stage I decubitus ulcer and pressure area
0.009 0.991 0.000
M43.08 Spondylolysis (Sacral and sacrococcygeal region)
0.000 0.991 0.009
M43.07 Spondylolysis (Lumbosacral region)
0.000 0.991 0.009
M43.05 Spondylolysis (Thoracolumbar region)
0.000 0.991 0.009
M43.04 Spondylolysis (Thoracic region)
0.000 0.991 0.009
M43.03 Spondylolysis (Cervicothoracic region)
0.000 0.991 0.009
M43.01 Spondylolysis (Occipito-atlanto-axial region)
0.000 0.991 0.009
M43.00 Spondylolysis (Multiple sites in spine)
0.000 0.991 0.009
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.009 0.991 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.009 0.991 0.000
T42.1 Iminostilbenes
0.009 0.991 0.000
L89.3 Stage IV decubitus ulcer
0.009 0.991 0.000
E21.4 Other specified disorders of parathyroid gland
0.009 0.991 0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.009 0.991 0.000
T36 Poisoning by systemic antibiotics
0.009 0.991 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.008 0.991 0.000
M43.02 Spondylolysis (Cervical region)
0.000 0.991 0.008
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.008 0.991 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.008 0.992 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.008 0.992 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.008 0.992 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.008 0.992 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.008 0.992 0.000
L89.2 Stage III decubitus ulcer
0.008 0.992 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.008 0.992 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.008 0.992 0.000
E87.0 Hyperosmolality and hypernatraemia
0.000 0.992 0.008
M43.29 Other fusion of spine (Site unspecified)
0.000 0.992 0.007
M43.28 Other fusion of spine (Sacral and sacrococcygeal region)
0.000 0.992 0.007
M43.27 Other fusion of spine (Lumbosacral region)
0.000 0.992 0.007
M43.26 Other fusion of spine (Lumbar region)
0.000 0.992 0.007
M43.25 Other fusion of spine (Thoracolumbar region)
0.000 0.992 0.007
M43.24 Other fusion of spine (Thoracic region)
0.000 0.992 0.007
M43.23 Other fusion of spine (Cervicothoracic region)
0.000 0.992 0.007
M43.22 Other fusion of spine (Cervical region)
0.000 0.992 0.007
M43.21 Other fusion of spine (Occipito-atlanto-axial region)
0.000 0.992 0.007
M43.20 Other fusion of spine (Multiple sites in spine)
0.000 0.992 0.007
M43.39 Recurrent atlantoaxial subluxation with myelopathy (Site unspecified)
0.000 0.992 0.007
M43.38 Recurrent atlantoaxial subluxation with myelopathy (Sacral and sacrococcygeal region)
0.000 0.992 0.007
M43.37 Recurrent atlantoaxial subluxation with myelopathy (Lumbosacral region)
0.000 0.992 0.007
M43.36 Recurrent atlantoaxial subluxation with myelopathy (Lumbar region)
0.000 0.992 0.007
M43.35 Recurrent atlantoaxial subluxation with myelopathy (Thoracolumbar region)
0.000 0.992 0.007
M43.34 Recurrent atlantoaxial subluxation with myelopathy (Thoracic region)
0.000 0.992 0.007
M43.33 Recurrent atlantoaxial subluxation with myelopathy (Cervicothoracic region)
0.000 0.992 0.007
M43.32 Recurrent atlantoaxial subluxation with myelopathy (Cervical region)
0.000 0.992 0.007
M43.31 Recurrent atlantoaxial subluxation with myelopathy (Occipito-atlanto-axial region)
0.000 0.992 0.007
M43.30 Recurrent atlantoaxial subluxation with myelopathy (Multiple sites in spine)
0.000 0.992 0.007
M43.49 Other recurrent atlantoaxial subluxation-Site unspe
0.000 0.992 0.007
M43.48 Other recurrent atlantoaxial subluxation-Sacral/sacrococ
0.000 0.992 0.007
M43.47 Other recurrent atlantoaxial subluxation-Lumbosacral
0.000 0.992 0.007
M43.46 Other recurrent atlantoaxial subluxation-Lumbar
0.000 0.992 0.007
M43.45 Other recurrent atlantoaxial subluxation-Thoracolumbar
0.000 0.992 0.007
M43.44 Other recurrent atlantoaxial subluxation-Thoracic
0.000 0.992 0.007
M43.43 Other recurrent atlantoaxial subluxation-Cervicothoracic
0.000 0.992 0.007
M43.42 Other recurrent atlantoaxial subluxation-Cervical
0.000 0.992 0.007
M43.41 Other recurrent atlantoaxial subluxation-Occipit-atl-axl
0.000 0.992 0.007
M43.40 Other recurrent atlantoaxial subluxation-Mult site
0.000 0.992 0.007
M43.59 Other recurrent vertebral subluxation (Site unspecified)
0.000 0.992 0.007
M43.58 Other recurrent vertebral subluxation (Sacral and sacrococcygeal region)
0.000 0.992 0.007
M43.57 Other recurrent vertebral subluxation (Lumbosacral region)
0.000 0.992 0.007
M43.56 Other recurrent vertebral subluxation (Lumbar region)
0.000 0.992 0.007
M43.55 Other recurrent vertebral subluxation (Thoracolumbar region)
0.000 0.992 0.007
M43.54 Other recurrent vertebral subluxation (Thoracic region)
0.000 0.992 0.007
M43.53 Other recurrent vertebral subluxation (Cervicothoracic region)
0.000 0.992 0.007
M43.52 Other recurrent vertebral subluxation (Cervical region)
0.000 0.992 0.007
M43.51 Other recurrent vertebral subluxation-Occipit-atl-axl
0.000 0.992 0.007
M43.50 Other recurrent vertebral subluxation (Multiple sites in spine)
0.000 0.992 0.007
M43.89 Other specified deforming dorsopathies (Site unspecified)
0.000 0.992 0.007
M43.88 Other specified deforming dorsopathies (Sacral and sacrococcygeal region)
0.000 0.992 0.007
M43.87 Other specified deforming dorsopathies (Lumbosacral region)
0.000 0.992 0.007
M43.86 Other specified deforming dorsopathies (Lumbar region)
0.000 0.992 0.007
M43.85 Other specified deforming dorsopathies (Thoracolumbar region)
0.000 0.992 0.007
M43.84 Other specified deforming dorsopathies (Thoracic region)
0.000 0.992 0.007
M43.83 Other specified deforming dorsopathies (Cervicothoracic region)
0.000 0.992 0.007
M43.82 Other specified deforming dorsopathies (Cervical region)
0.000 0.992 0.007
M43.81 Other specified deforming dorsopathies (Occipito-atlanto-axial region)
0.000 0.992 0.007
M43.80 Other specified deforming dorsopathies (Multiple sites in spine)
0.000 0.992 0.007
M43.99 Deforming dorsopathy, unspecified (Site unspecified)
0.000 0.992 0.007
M43.98 Deforming dorsopathy, unspecified (Sacral and sacrococcygeal region)
0.000 0.992 0.007
M43.97 Deforming dorsopathy, unspecified (Lumbosacral region)
0.000 0.992 0.007
M43.96 Deforming dorsopathy, unspecified (Lumbar region)
0.000 0.992 0.007
M43.95 Deforming dorsopathy, unspecified (Thoracolumbar region)
0.000 0.992 0.007
M43.94 Deforming dorsopathy, unspecified (Thoracic region)
0.000 0.992 0.007
M43.93 Deforming dorsopathy, unspecified (Cervicothoracic region)
0.000 0.992 0.007
M43.92 Deforming dorsopathy, unspecified (Cervical region)
0.000 0.992 0.007
M43.91 Deforming dorsopathy, unspecified (Occipito-atlanto-axial region)
0.000 0.992 0.007
M43.90 Deforming dorsopathy, unspecified (Multiple sites in spine)
0.000 0.992 0.007
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.007 0.992 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.007 0.993 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.007 0.993 0.000
M43.69 Torticollis-Site unspe
0.000 0.993 0.007
M43.68 Torticollis-Sacral/sacrococ
0.000 0.993 0.007
M43.67 Torticollis-Lumbosacral
0.000 0.993 0.007
M43.66 Torticollis-Lumbar
0.000 0.993 0.007
M43.65 Torticollis-Thoracolumbar
0.000 0.993 0.007
M43.64 Torticollis-Thoracic
0.000 0.993 0.007
M43.63 Torticollis-Cervicothoracic
0.000 0.993 0.007
M43.61 Torticollis-Occipit-atl-axl
0.000 0.993 0.007
M43.60 Torticollis-Mult site
0.000 0.993 0.007
T42.5 Mixed antiepileptics, not elsewhere classified
0.007 0.993 0.000
T42.3 Barbiturates
0.007 0.993 0.000
T42.2 Succinimides and oxazolidinediones
0.007 0.993 0.000
E16.2 Hypoglycaemia, unspecified
0.000 0.993 0.007
T38.8 Other and unspecified hormones and their synthetic substitutes
0.007 0.993 0.000
M43.62 Torticollis-Cervical
0.000 0.993 0.007
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.007 0.993 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.007 0.993 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.007 0.993 0.000
T36.0 Penicillins
0.007 0.993 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.007 0.993 0.000
T38.9 Other and unspecified hormone antagonists
0.007 0.993 0.000
T38.7 Androgens and anabolic congeners
0.007 0.993 0.000
T38.5 Other oestrogens and progestogens
0.007 0.993 0.000
T38.4 Oral contraceptives
0.007 0.993 0.000
T38.2 Antithyroid drugs
0.007 0.993 0.000
T38.0 Glucocorticoids and synthetic analogues
0.007 0.993 0.000
T36.3 Macrolides
0.007 0.993 0.000
U80 Agent resistant to penicillin and related antibiotics
0.000 0.993 0.007
T50.4 Drugs affecting uric acid metabolism
0.007 0.993 0.000
U80.8 Agent resistant to other penicillin-related antibiotic
0.000 0.993 0.007
T36.9 Systemic antibiotic, unspecified
0.006 0.994 0.000
T36.8 Other systemic antibiotics
0.006 0.994 0.000
T36.7 Antifungal antibiotics, systemically used
0.006 0.994 0.000
T36.6 Rifamycins
0.006 0.994 0.000
T36.5 Aminoglycosides
0.006 0.994 0.000
T36.4 Tetracyclines
0.006 0.994 0.000
T36.2 Chloramphenicol group
0.006 0.994 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.006 0.994 0.000
T42.0 Hydantoin derivatives
0.006 0.994 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.006 0.994 0.000
T48.5 Anti-common-cold drugs
0.006 0.994 0.000
T48.4 Expectorants
0.006 0.994 0.000
T48.3 Antitussives
0.006 0.994 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.006 0.994 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.006 0.994 0.000
T48.0 Oxytocic drugs
0.006 0.994 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.006 0.994 0.000
T37.5 Antiviral drugs
0.006 0.994 0.000
T37.4 Anthelminthics
0.006 0.994 0.000
T37.3 Other antiprotozoal drugs
0.006 0.994 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.006 0.994 0.000
T37.1 Antimycobacterial drugs
0.006 0.994 0.000
T37.0 Sulphonamides
0.006 0.994 0.000
T38.1 Thyroid hormones and substitutes
0.006 0.994 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.006 0.994 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.006 0.994 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.006 0.994 0.000
T47.4 Other laxatives
0.006 0.994 0.000
T50.8 Diagnostic agents
0.006 0.994 0.000
T50.7 Analeptics and opioid receptor antagonists
0.006 0.994 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.006 0.994 0.000
T50.5 Appetite depressants
0.006 0.994 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.006 0.994 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.006 0.994 0.000
T50.1 Loop [high-ceiling] diuretics
0.006 0.994 0.000
T50.0 Mineralocorticoids and their antagonists
0.006 0.994 0.000
T41.5 Therapeutic gases
0.006 0.994 0.000
T41.4 Anaesthetic, unspecified
0.006 0.994 0.000
T41.3 Local anaesthetics
0.006 0.994 0.000
T41.2 Other and unspecified general anaesthetics
0.006 0.994 0.000
T41.1 Intravenous anaesthetics
0.006 0.994 0.000
T41.0 Inhaled anaesthetics
0.006 0.994 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.006 0.994 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.006 0.994 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.006 0.994 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.006 0.994 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.006 0.994 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.006 0.994 0.000
T44.0 Anticholinesterase agents
0.006 0.994 0.000
T49.9 Topical agent, unspecified
0.006 0.994 0.000
T49.8 Other topical agents
0.006 0.994 0.000
T49.7 Dental drugs, topically applied
0.006 0.994 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.006 0.994 0.000
T49.5 Ophthalmological drugs and preparations
0.006 0.994 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.006 0.994 0.000
T49.3 Emollients, demulcents and protectants
0.006 0.994 0.000
T49.2 Local astringents and local detergents
0.006 0.994 0.000
T49.1 Antipruritics
0.006 0.994 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.006 0.994 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.006 0.994 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.006 0.994 0.000
T47.7 Emetics
0.006 0.994 0.000
T47.6 Antidiarrhoeal drugs
0.006 0.994 0.000
T47.5 Digestants
0.006 0.994 0.000
T47.3 Saline and osmotic laxatives
0.006 0.994 0.000
T47.2 Stimulant laxatives
0.006 0.994 0.000
T47.0 Histamine H(2)-receptor antagonists
0.006 0.994 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.005 0.994 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.005 0.994 0.000
T46.7 Peripheral vasodilators
0.005 0.994 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.006 0.994 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.005 0.994 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.005 0.994 0.000
T46.1 Calcium-channel blockers
0.005 0.994 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.005 0.994 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.005 0.994 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.005 0.994 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.005 0.995 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.005 0.995 0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
0.005 0.995 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.005 0.995 0.000
T45.8 Other primarily systemic and haematological agents
0.005 0.995 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.005 0.995 0.000
T45.6 Fibrinolysis-affecting drugs
0.005 0.995 0.000
T45.4 Iron and its compounds
0.005 0.995 0.000
T45.3 Enzymes, not elsewhere classified
0.005 0.995 0.000
N99.4 Postprocedural pelvic peritoneal adhesions
0.005 0.995 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.005 0.995 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.005 0.995 0.000
T45.5 Anticoagulants
0.005 0.995 0.000
E16 Other disorders of pancreatic internal secretion
0.000 0.995 0.005
T45.0 Antiallergic and antiemetic drugs
0.004 0.995 0.000
H04.1 Other disorders of lachrymal gland
0.000 0.996 0.004
T45.2 Vitamins, not elsewhere classified
0.004 0.996 0.000
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere
0.004 0.996 0.000
M87.20 Osteonecrosis due to previous trauma (Multiple sites)
0.000 0.996 0.004
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.996 0.004
N73.9 Female pelvic inflammatory disease, unspecified
0.004 0.996 0.000
E22.0 Acromegaly and pituitary gigantism
0.004 0.996 0.000
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)
0.004 0.996 0.000
M24.13 Other articular cartilage disorders (Forearm)
0.000 0.996 0.004
N31.8 Other neuromuscular dysfunction of bladder
0.000 0.996 0.004
E22 Hyperfunction of pituitary gland
0.004 0.996 0.000
E24 Cushing's syndrome
0.004 0.996 0.000
U80.0 Penicillin resistant agent
0.000 0.996 0.004
M05-M14 Inflammatory polyarthropathies
0.004 0.996 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.004 0.996 0.000
M24.11 Other articular cartilage disorders (Shoulder region)
0.000 0.996 0.004
E20-E35 Disorders of other endocrine glands
0.004 0.996 0.000
C18.6 Descending colon
0.004 0.996 0.000
E24.9 Cushing's syndrome, unspecified
0.004 0.996 0.000
M24.1 Other articular cartilage disorders
0.000 0.996 0.004
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.996 0.003
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.996 0.003
E16.4 Abnormal secretion of gastrin
0.000 0.996 0.003
E16.3 Increased secretion of glucagon
0.000 0.996 0.003
N70-N77 Inflammatory diseases of female pelvic organs
0.004 0.996 0.000
K57.1 Diverticular disease of small intestine without perforation or abscess
0.000 0.996 0.004
T42.4 Benzodiazepines
0.004 0.996 0.000
M54.46 Lumbago with sciatica (Lumbar region)
0.000 0.996 0.004
F10.0 Acute intoxication
0.000 0.996 0.004
M87.2 Osteonecrosis due to previous trauma
0.000 0.996 0.003
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)
0.000 0.997 0.003
S32.00 Fracture of lumbar vertebra (closed)
0.003 0.997 0.000
E24.0 Pituitary-dependent Cushing's disease
0.003 0.997 0.000
M54.47 Lumbago with sciatica (Lumbosacral region)
0.000 0.997 0.003
N77.8 Vulvovaginal ulceration and inflammation in other diseases classified elsewhere
0.003 0.997 0.000
N77.0 Ulceration of vulva in infectious and parasitic diseases classified elsewhere
0.003 0.997 0.000
E16.1 Other hypoglycaemia
0.000 0.997 0.003
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.003 0.997 0.000
E29 Testicular dysfunction
0.003 0.997 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.003 0.997 0.000
M87.9 Osteonecrosis, unspecified
0.000 0.997 0.003
E25 Adrenogenital disorders
0.003 0.997 0.000
E22.1 Hyperprolactinaemia
0.003 0.997 0.000
H02.0 Entropion and trichiasis of eyelid
0.003 0.997 0.000
G91.9 Hydrocephalus, unspecified
0.003 0.997 0.000
E24.2 Drug-induced Cushing's syndrome
0.003 0.997 0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.003 0.997 0.000
M08 Juvenile arthritis
0.003 0.997 0.000
M24.15 Other articular cartilage disorders (Pelvic region and thigh)
0.000 0.997 0.003
E22.9 Hyperfunction of pituitary gland, unspecified
0.003 0.997 0.000
E22.8 Other hyperfunction of pituitary gland
0.003 0.997 0.000
E24.8 Other Cushing's syndrome
0.003 0.997 0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.003 0.997 0.000
E24.3 Ectopic ACTH syndrome
0.003 0.997 0.000
E24.1 Nelson's syndrome
0.003 0.997 0.000
M09 Juvenile arthritis in diseases classified elsewhere
0.003 0.997 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.003 0.997 0.000
T40.8 Lysergide [LSD]
0.003 0.997 0.000
T40.7 Cannabis (derivatives)
0.003 0.997 0.000
T40.3 Methadone
0.003 0.997 0.000
T40.1 Heroin
0.003 0.997 0.000
T40.0 Opium
0.003 0.997 0.000
N73 Other female pelvic inflammatory diseases
0.003 0.997 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.003 0.997 0.000
E32 Diseases of thymus
0.003 0.997 0.000
E31 Polyglandular dysfunction
0.003 0.997 0.000
E30 Disorders of puberty, not elsewhere classified
0.003 0.997 0.000
E26 Hyperaldosteronism
0.003 0.997 0.000
M24.16 Other articular cartilage disorders (Lower leg)
0.000 0.997 0.003
C85.7 Other specified types of non-Hodgkin's lymphoma
0.003 0.997 0.000
M87 Osteonecrosis
0.000 0.997 0.003
M12 Other specific arthropathies
0.003 0.997 0.000
E29.1 Testicular hypofunction
0.003 0.997 0.000
M87.91 Osteonecrosis, unspecified (Shoulder region)
0.000 0.997 0.003
K51.3 Ulcerative (chronic) rectosigmoiditis
0.003 0.997 0.000
M24.19 Other articular cartilage disorders (Site unspecified)
0.000 0.997 0.003
M24.18 Other articular cartilage disorders (Other)
0.000 0.997 0.003
M24.14 Other articular cartilage disorders (Hand)
0.000 0.997 0.003
M24.12 Other articular cartilage disorders (Upper arm)
0.000 0.997 0.003
M24.10 Other articular cartilage disorders (Multiple sites)
0.000 0.997 0.003
E34 Other endocrine disorders
0.003 0.997 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.003 0.997 0.000
T84.2 Mechanical complication of internal fixation device of other bones
0.000 0.997 0.003
M14 Arthropathies in other diseases classified elsewhere
0.003 0.997 0.000
T40.5 Cocaine
0.003 0.997 0.000
N74 Female pelvic inflammatory disorders in diseases classified elsewhere
0.003 0.997 0.000
M40-M43 Deforming dorsopathies
0.000 0.997 0.003
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.003 0.997 0.000
I20.0 Unstable angina
0.000 0.997 0.003
M87.8 Other osteonecrosis
0.000 0.997 0.003
M87.29 Osteonecrosis due to previous trauma (Site unspecified)
0.000 0.997 0.003
M87.28 Osteonecrosis due to previous trauma (Other)
0.000 0.997 0.003
M87.26 Osteonecrosis due to previous trauma (Lower leg)
0.000 0.997 0.003
M87.24 Osteonecrosis due to previous trauma (Hand)
0.000 0.997 0.003
M87.23 Osteonecrosis due to previous trauma (Forearm)
0.000 0.997 0.003
M87.22 Osteonecrosis due to previous trauma (Upper arm)
0.000 0.997 0.003
M87.21 Osteonecrosis due to previous trauma (Shoulder region)
0.000 0.997 0.003
M87.85 Other osteonecrosis (Pelvic region and thigh)
0.000 0.997 0.003
M87.25 Osteonecrosis due to previous trauma (Pelvic region and thigh)
0.000 0.997 0.003
M54.4 Lumbago with sciatica
0.000 0.997 0.003
M87.27 Osteonecrosis due to previous trauma (Ankle and foot)
0.000 0.997 0.003
M87.97 Osteonecrosis, unspecified (Ankle and foot)
0.000 0.997 0.003
N73.5 Female pelvic peritonitis, unspecified
0.003 0.997 0.000
M87.98 Osteonecrosis, unspecified (Other)
0.000 0.997 0.003
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use
0.000 0.997 0.003
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.003 0.997 0.000
C85.0 Lymphosarcoma
0.003 0.997 0.000
E29.9 Testicular dysfunction, unspecified
0.002 0.997 0.000
E29.8 Other testicular dysfunction
0.002 0.997 0.000
E29.0 Testicular hyperfunction
0.002 0.997 0.000
G51.3 Clonic hemifacial spasm
0.000 0.997 0.003
M08.0 Juvenile rheumatoid arthritis
0.002 0.997 0.000
T39.4 Antirheumatics, not elsewhere classified
0.003 0.997 0.000
T39.2 Pyrazolone derivatives
0.003 0.997 0.000
T40.6 Other and unspecified narcotics
0.002 0.997 0.000
M87.99 Osteonecrosis, unspecified (Site unspecified)
0.000 0.997 0.002
M87.94 Osteonecrosis, unspecified (Hand)
0.000 0.997 0.002
M87.93 Osteonecrosis, unspecified (Forearm)
0.000 0.997 0.002
M87.92 Osteonecrosis, unspecified (Upper arm)
0.000 0.997 0.002
M87.90 Osteonecrosis, unspecified (Multiple sites)
0.000 0.997 0.002
E25.9 Adrenogenital disorder, unspecified
0.002 0.997 0.000
E25.8 Other adrenogenital disorders
0.002 0.997 0.000
M24.17 Other articular cartilage disorders (Ankle and foot)
0.000 0.997 0.002
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.002 0.997 0.000
M08.9 Juvenile arthritis, unspecified
0.002 0.997 0.000
M08.8 Other juvenile arthritis
0.002 0.997 0.000
M08.4 Pauciarticular juvenile arthritis
0.002 0.997 0.000
M08.3 Juvenile polyarthritis (seronegative)
0.002 0.997 0.000
M08.2 Juvenile arthritis with systemic onset
0.002 0.997 0.000
M08.1 Juvenile ankylosing spondylitis
0.002 0.997 0.000
J33.9 Nasal polyp, unspecified
0.003 0.997 0.000
L27.0 Generalised skin eruption due to drugs and medicaments
0.000 0.997 0.003
T39.0 Salicylates
0.002 0.997 0.000
E20 Hypoparathyroidism
0.002 0.997 0.000
E26.9 Hyperaldosteronism, unspecified
0.002 0.998 0.000
N73.8 Other specified female pelvic inflammatory diseases
0.002 0.998 0.000
L27.1 Localised skin eruption due to drugs and medicaments
0.000 0.998 0.002
M09.8 Juvenile arthritis in other diseases classified elsewhere
0.002 0.998 0.000
M09.2 Juvenile arthritis in ulcerative colitis
0.002 0.998 0.000
M09.1 Juvenile arthritis in Crohn's disease [regional enteritis]
0.002 0.998 0.000
M09.0 Juvenile arthritis in psoriasis
0.002 0.998 0.000
N99.2 Postprocedural adhesions of vagina
0.002 0.998 0.000
R06.4 Hyperventilation
0.000 0.998 0.002
N73.4 Female chronic pelvic peritonitis
0.002 0.998 0.000
N73.3 Female acute pelvic peritonitis
0.002 0.998 0.000
N73.2 Unspecified parametritis and pelvic cellulitis
0.002 0.998 0.000
C18.3 Hepatic flexure
0.002 0.998 0.000
C18.1 Appendix
0.002 0.998 0.000
E26.8 Other hyperaldosteronism
0.002 0.998 0.000
E26.1 Secondary hyperaldosteronism
0.002 0.998 0.000
E30.9 Disorder of puberty, unspecified
0.002 0.998 0.000
E30.8 Other disorders of puberty
0.002 0.998 0.000
E30.1 Precocious puberty
0.002 0.998 0.000
E30.0 Delayed puberty
0.002 0.998 0.000
E31.9 Polyglandular dysfunction, unspecified
0.002 0.998 0.000
E31.8 Other polyglandular dysfunction
0.002 0.998 0.000
E31.1 Polyglandular hyperfunction
0.002 0.998 0.000
E31.0 Autoimmune polyglandular failure
0.002 0.998 0.000
E32.9 Disease of thymus, unspecified
0.002 0.998 0.000
E32.8 Other diseases of thymus
0.002 0.998 0.000
E32.1 Abscess of thymus
0.002 0.998 0.000
E32.0 Persistent hyperplasia of thymus
0.002 0.998 0.000
E34.9 Endocrine disorder, unspecified
0.002 0.998 0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.002 0.998 0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.002 0.998 0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.002 0.998 0.000
M12.2 Villonodular synovitis (pigmented)
0.002 0.998 0.000
M87.3 Other secondary osteonecrosis
0.000 0.998 0.002
M87.1 Osteonecrosis due to drugs
0.000 0.998 0.002
M87.0 Idiopathic aseptic necrosis of bone
0.000 0.998 0.002
M12.8 Other specific arthropathies, not elsewhere classified
0.002 0.998 0.000
M12.5 Traumatic arthropathy
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.